![]() | Only 14 pages are availabe for public view |
Abstract This study is now redirected to Avoid the unneeded use of high doses of RAI-131 in post-operative ablation of residual thyroid tissue in cases of differentiated thyroid cancer with no gross residual disease or distal metastasis and to increase patient convenience, through administering low dose of 131I to the postoperative patients indicated for ablation guided by pathology report, operative data, and trustable neck U.S. This study suggests that the low dose RAI-131 is as effective as the high doses in post- operative ablation of the residual thyroid tissue in patients of differentiated cancer with no gross residual disease or distal metastasis |